Oxford Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OXFORD PHARMS, and what generic and branded alternatives to OXFORD PHARMS drugs are available?
OXFORD PHARMS has thirty-three approved drugs.
Summary for Oxford Pharms
| US Patents: | 0 |
| Tradenames: | 30 |
| Ingredients: | 30 |
| NDAs: | 33 |
Drugs and US Patents for Oxford Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oxford Pharms | SPIRONOLACTONE | spironolactone | TABLET;ORAL | 040750-001 | Aug 29, 2006 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Oxford Pharms | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | TABLET;ORAL | 087059-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Oxford Pharms | BACLOFEN | baclofen | TABLET;ORAL | 077088-001 | Oct 31, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
